Become a Member

cat_bastet

Microblogs

This isn’t about one specific investment, I would like to get opinions from the very smart investors here about the idea of spreading your assets around internationally. I subscribe to International Living, and recently they sent out an email about a publication from Casey Research entitled Going Global 2014. (see it here at https://www.caseyresearch.com/cm/going-global-2014 ) […]

Recent Author Comments

On The Second Coming of TransEnterix?

Thanks for the link Ben[...]

Go to Comment »
On The Second Coming of TransEnterix?

OK, oops, i goofed on my previous comment, it's got a paragraph at the end I meant to cut. I don't see any way to edit my own comment, is there a way?[...]

Go to Comment »
On The Second Coming of TransEnterix?

Hey all, I've been awol for quite a while, got a lot of reading to catch up on, but I have a couple of questions. Is the spreadsheet that was created quite a while ago listing the 'upstart biotech' stocks still being maintained, and if so can someone prov[...]

Go to Comment »
On Microblog: Special Update on Cellceutix

Thank you for the timely update, Dr. KSS. I am long CTIX and will remain so based on their pipeline, though like you I hope there are no more nasty surprises waiting in the wings. All my biotech positions are relatively small so seeing any one of them go[...]

Go to Comment »
On Microblog: Yellow Eyes, White Powders, and an Unknown Nordic Biotech That May Green Things Up for Investors

Alan, does TinyURL work in the UK? Your 525-character link to the candy cig images was reduced to the 26-character http://tinyurl.com/kdudm88 by tinyurl.com (in case it's a site you are not familiar with)[...]

Go to Comment »
On Microblog: Is This Red-Hot New "Blood Stock" Any Bloody Good as an Investment?

I never thought GILDs drugs were overpriced, I've been following these discussions since the 'mother thread' and understand completely how this is an immense improvement vs. SoC. I just think Congress needs someone like you, Dr. KSS, to make THEM understa[...]

Go to Comment »
On Microblog: Is This Red-Hot New "Blood Stock" Any Bloody Good as an Investment?

Below is a quote from an AAII newsletter I subscribe to. Has anyone heard anything about Congress discussing "legislative solutions" (see the final sentence in the quote) to what they evidently feel are inflated drug prices? It appears to me that the gov[...]

Go to Comment »
On Microblog: Is This Red-Hot New "Blood Stock" Any Bloody Good as an Investment?

Just to the end of paragraph five and I have to stop and comment already. "Places where your own cultural rules and norms are utterly inapplicable are great places to go for vacations." I'm going to embroider that on a sampler and hang it over my compute[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

Well I spoke too soon - when I talked to the guys at Scottrade they did not tell me anything about a fee, but I did just receive an e-mail calling it a "non-mandatory reorg/tender and it does mention the $25 fee. I would probably just sell and re-buy exce[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

I just did my conversion at Scottrade and did not get charged any fees. Don't know why you were told that.[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

Thank you, thumb. I did not mean my comment about not finding CUR on the spreadsheet to be in any way a criticism, I understand it is a work in progress but I must have missed your statement about adding a stock to it if we would send you a link. Would t[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

Thank you, Dr. KSS - a very helpful and educational reply, as always.[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

Dennis, "the bomb" is somewhat counter-intuitive urban slang for awesome - nothing to be concerned about :)[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

I have seen Neuralstem (CUR) mentioned in a few of the threads going back as far as the 'mother thread', but no one has so far published any investigative work and it's not listed on the spreadsheet. I'm still educating myself - with a lot of help from y'[...]

Go to Comment »
On Microblog: Is Any Big Pharma Outfit NOT Interested in Buying This Little-Known Biotech?

Welcome, Tim! This is an amazing place to spend some time. Go back and read Dr. KSS's other articles when you can, you'll find the time spent well worth while![...]

Go to Comment »
On Microblog: Another Hot Australian Biotech: Is Biotron Right for Your Portfolio?

I am waaay behind the fair here so I doubt anyone will even see this comment except for those of us (like me) who are playing catch-up on reading, but OPKO has been having a long run of insider buying and it's interesting to me to see a connection with the[...]

Go to Comment »
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences

Thanks, as usual, to everyone here for financial and medical education and camaraderie accompanied by a soupçon of humor. Love this site more and more every day. I just got off the coumadin roller-coaster a few months ago but my husband just took my pla[...]

Go to Comment »
On Microblog: NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It

Thank you, David (#591). I will look into venlafaxine and we'll check it out with my husband's doctor. The whole drug field is a scary one, so hard to know what is the right or wrong thing to take.[...]

Go to Comment »
On Microblog: NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It

Dr. KSS, I wonder if you have ever posted anything publicly elsewhere that expands on your post #578 (and #567 on the 'mother thread') about "garbage drugs". I was tempted to ask you to consider posting a column on this topic here on GS since you are help[...]

Go to Comment »
On Microblog: NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It

I hope that word gets out about dalbavancin quickly. If it had been out 3 years ago it would have saved my husband a seizure and a 2-day hospital stay because he kept throwing up the oral antibiotics (along with all his other meds, which led to the seizur[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info